BB Biotech AG announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced total revenue was CHF 467,000 compared to CHF 1.192 million a year ago. Net loss was CHF 335.805 million compared to CHF 98.582 million a year ago. Basic loss per share was CHF 6.06 compared to CHF 1.78 a year ago. For the half year, total revenue was CHF 579.336 million compared to CHF 3.783 million a year ago. Net income was CHF 553.976 million compared to net loss of CHF 70.355 million a year ago. Basic earnings per share was CHF 10 compared to basic loss per share of CHF 1.27 a year ago.